title: Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings.
abstract: Schizophrenia may result from the concerted action of several pathophysiological factors. This pilot study compared the distribution of measurements of three such putative factors in 11 schizophrenics and their siblings: a neurophysiological deficit in auditory sensory gating, diminished hippocampal volume, and increased catecholamine metabolism. Abnormal auditory sensory gating was found in all schizophrenics in the 11 families studied and in 8 of their 20 siblings. Compared with the schizophrenics, the clinically unaffected siblings with abnormal auditory gating had larger hippocampal volume. There was no similar difference for the siblings with normal gating. The siblings with abnormal auditory gating also had lower homovanillic acid levels than the other siblings. The data suggest that a familial neuronal deficit, identified by diminished sensory gating, may be a necessary, but not sufficient factor in the pathogenesis of schizophrenia. Individuals with this deficit are generally clinically unaffected, except for schizophrenics, who also have other abnormalities, such as diminished hippocampal volume and increased catecholamine metabolism.
authors.affiliation: Department of Psychiatry, Denver VA Medical Center, CO 80262.
authors.forename: M C
authors.initials: MC
authors.lastname: Waldo
authors.forename: E
authors.initials: E
authors.lastname: Cawthra
authors.forename: L E
authors.initials: LE
authors.lastname: Adler
authors.forename: S
authors.initials: S
authors.lastname: Dubester
authors.forename: M
authors.initials: M
authors.lastname: Staunton
authors.forename: H
authors.initials: H
authors.lastname: Nagamoto
authors.forename: N
authors.initials: N
authors.lastname: Baker
authors.forename: A
authors.initials: A
authors.lastname: Madison
authors.forename: J
authors.initials: J
authors.lastname: Simon
authors.forename: A
authors.initials: A
authors.lastname: Scherzinger
mesh_terms: D000161:Acoustic Stimulation; D000328:Adult; D000679:Amygdala / Q000473:pathology / Q000503:physiopathology; D001143:Arousal / Q000235:genetics / Q000502:physiology*; D001288:Attention / Q000502:physiology*; D002395:Catecholamines / Q000097:blood*; D002908:Chronic Disease; D004298:Dopamine / Q000502:physiology; D005072:Evoked Potentials, Auditory / Q000235:genetics / Q000502:physiology*; D005260:Female; D006185:Habituation, Psychophysiologic / Q000235:genetics / Q000502:physiology*; D006624:Hippocampus / Q000473:pathology / Q000503:physiopathology*; D006719:Homovanillic Acid / Q000097:blood; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000097:blood; D009433:Neural Inhibition / Q000235:genetics / Q000502:physiology; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000235:genetics / Q000503:physiopathology*; D012565:Schizophrenic Psychology; D014642:Vanilmandelic Acid / Q000097:blood
chemical_list: D002395:Catecholamines; D008734:Methoxyhydroxyphenylglycol; D014642:Vanilmandelic Acid; D004298:Dopamine; D006719:Homovanillic Acid